The trial aims to assess the safety and tolerability of GIGA-564 in patients with metastatic or locally advanced solid ...

Q1 2024 Earnings Call Transcript May 14, 2024 Grifols, S.A. misses on earnings expectations. Reported EPS is $0.07 EPS, ...

Deutsche Bank raised the price target for the Grifols SA ADR (NASDAQ:GRFS) stock from “a Hold” to “a Sell”. The rating was released on March 12, 2024, according to finviz.

The Intravenous Immunoglobulin (IVIG) market is projected to experience significant growth, with market size increasing from USD 13.6 billion in 2022 to around USD 24.4 billion by 2032, registering a ...

The scientist investigates the rejuvenating potential of young blood, and has created a system that calculates the age of ...

Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and ...

Grifols SA releases earnings for Q1 on May 14.Wall Street analysts are expecting earnings per share of €0.098.Watch Grifols SA stock price in ...

Grifols reveals earnings for Q1 on May 14.Wall Street analysts are expecting earnings per share of $0.106.Follow Grifols stock price in real-time ...

Grifols SA shares fell after short-seller Gotham City Research released a new report accusing the healthcare company of ...

Medical Nutrition Market is Segmented by Type (Pediatric Nutrition, Adult Nutrition, Geriatric Nutrition, Sport Nutrition), ...

A well-publicized short bet by General Industrial Partners on Spanish company Grifols SA helped the hedge fund earn ...